Giuseppe
Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]
A Hamprecht (
)<SUP>1</SUP>, D Buchheidt<SUP>2</SUP>, J J Vehreschild<SUP>3</SUP>, O A Cornely<SUP>3</SUP><SUP>,4</SUP>, B Spiess<SUP>2</SUP>, G Plum<SUP>1</SUP>, T V Halbsguth<SUP>3</SUP>, N Kutsch<SUP>3</SUP>, D Stippel<SUP>5</SUP>, P Kahl<SUP>6</SUP>, T Persigehl<SUP>7</SUP>, A Steinbach<SUP>3</SUP>, B Bos<SUP>3</SUP>, M Hallek<SUP>3</SUP>, M J Vehreschild<SUP>3</SUP>
Citation style for this article: Hamprecht A, Buchheidt D, Vehreschild JJ, Cornely OA, Spiess B, Plum G, Halbsguth TV, Kutsch N, Stippel D, Kahl P, Persigehl T, Steinbach A, Bos B, Hallek M, Vehreschild MJ. Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany . Euro Surveill. 2012;17(36)
ii=20262. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20262
Date of submission: 16 August 2012 <HR>We report the first culture-proven case of invasive aspergillosis (IA) caused by azole-resistant Aspergillus fumigatus in a patient with acute myeloid leukaemia in Germany. IA presented as breakthrough infection under posaconazole prophylaxis. Analysis of the resistance mechanism revealed the TR/L98H mutation in the cyp51A gene, which indicates an environmental origin of the strain. This case underscores the need for monitoring azole resistance in Aspergillus spp. and for routine susceptibility testing of moulds.
- -------
Eurosurveillance, Volume 17, Issue 36, 06 September 2012
Rapid communications
Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany
Rapid communications
Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany
A Hamprecht (
- Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany
- Third Department of Internal Medicine, Haematology and Oncology, Mannheim University Hospital, University of Heidelberg, Mannheim, Germany
- First Department of Internal Medicine, University of Cologne, Cologne, Germany
- Clinical Trials Centre Cologne, ZKS K?ln (BMBF 01KN1106), University of Cologne, Cologne, Germany
- Department of General, Visceral and Cancer Surgery, University of Cologne, Germany
- Institute of Pathology, University Hospital Cologne, Cologne, Germany
- Department of Radiology, University Hospital Cologne, Cologne Germany
Citation style for this article: Hamprecht A, Buchheidt D, Vehreschild JJ, Cornely OA, Spiess B, Plum G, Halbsguth TV, Kutsch N, Stippel D, Kahl P, Persigehl T, Steinbach A, Bos B, Hallek M, Vehreschild MJ. Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany . Euro Surveill. 2012;17(36)
Date of submission: 16 August 2012 <HR>We report the first culture-proven case of invasive aspergillosis (IA) caused by azole-resistant Aspergillus fumigatus in a patient with acute myeloid leukaemia in Germany. IA presented as breakthrough infection under posaconazole prophylaxis. Analysis of the resistance mechanism revealed the TR/L98H mutation in the cyp51A gene, which indicates an environmental origin of the strain. This case underscores the need for monitoring azole resistance in Aspergillus spp. and for routine susceptibility testing of moulds.